| The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice EM Rhea, AF Logsdon, KM Hansen, LM Williams, MJ Reed, KK Baumann, ... Nature neuroscience 24 (3), 368-378, 2021 | 422 | 2021 |
| Gut reactions: How the blood–brain barrier connects the microbiome and the brain AF Logsdon, MA Erickson, EM Rhea, TS Salameh, WA Banks Experimental Biology and Medicine 243 (2), 159-165, 2018 | 215 | 2018 |
| Role of the blood-brain barrier in central nervous system insulin resistance EM Rhea, WA Banks Frontiers in neuroscience 13, 457034, 2019 | 197 | 2019 |
| Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases B Meredith, Salameh AAPS J 17 (4), 780-7, 2015 | 197 | 2015 |
| Triglycerides cross the blood–brain barrier and induce central leptin and insulin receptor resistance WA Banks, SA Farr, TS Salameh, ML Niehoff, EM Rhea, JE Morley, ... International journal of obesity 42 (3), 391-397, 2018 | 174 | 2018 |
| Healthy aging and the blood–brain barrier WA Banks, MJ Reed, AF Logsdon, EM Rhea, MA Erickson Nature aging 1 (3), 243-254, 2021 | 154 | 2021 |
| Interactions of SARS-CoV-2 with the blood–brain barrier MA Erickson, EM Rhea, RC Knopp, WA Banks International Journal of Molecular Sciences 22 (5), 2681, 2021 | 141 | 2021 |
| Blood-brain barriers in obesity EM Rhea, TS Salameh, AF Logsdon, AJ Hanson, MA Erickson, WA Banks The AAPS journal 19, 921-930, 2017 | 132 | 2017 |
| Insulin transport across the blood–brain barrier can occur independently of the insulin receptor EM Rhea, C Rask‐Madsen, WA Banks The Journal of physiology 596 (19), 4753-4765, 2018 | 128 | 2018 |
| Mechanisms of ascorbic acid stimulation of norepinephrine synthesis in neuronal cells JM May, Z Qu, ME Meredith Biochemical and biophysical research communications 426 (1), 148-152, 2012 | 95 | 2012 |
| Low vitamin C and increased oxidative stress and cell death in mice that lack the sodium-dependent vitamin C transporter SVCT2 FE Harrison, SM Dawes, ME Meredith, VR Babaev, L Li, JM May Free Radical Biology and Medicine 49 (5), 821-829, 2010 | 95 | 2010 |
| Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer’s and Parkinson’s disease therapeutics TS Salameh, EM Rhea, K Talbot, WA Banks Biochemical pharmacology 180, 114187, 2020 | 78 | 2020 |
| Ghrelin transport across the blood–brain barrier can occur independently of the growth hormone secretagogue receptor EM Rhea, TS Salameh, S Gray, J Niu, WA Banks, J Tong Molecular metabolism 18, 88-96, 2018 | 78 | 2018 |
| Low ascorbic acid and increased oxidative stress in gulo (−/−) mice during development FE Harrison, ME Meredith, SM Dawes, JL Saskowski, JM May Brain research 1349, 143-152, 2010 | 73 | 2010 |
| Differential regulation of the ascorbic acid transporter SVCT2 during development and in response to ascorbic acid depletion ME Meredith, FE Harrison, JM May Biochemical and biophysical research communications 414 (4), 737-742, 2011 | 59 | 2011 |
| Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease TS Salameh, EM Rhea, WA Banks, AJ Hanson Experimental Biology and Medicine 241 (15), 1676-1683, 2016 | 48 | 2016 |
| Regulation of embryonic neurotransmitter and tyrosine hydroxylase protein levels by ascorbic acid ME Meredith, JM May Brain research 1539, 7-14, 2013 | 46 | 2013 |
| ApoE and cerebral insulin: trafficking, receptors, and resistance EM Rhea, J Raber, WA Banks Neurobiology of disease 137, 104755, 2020 | 44 | 2020 |
| Serum amyloid A: an ozone-induced circulating factor with potentially important functions in the lung-brain axis MA Erickson, J Jude, H Zhao, EM Rhea, TS Salameh, W Jester, S Pu, ... The FASEB Journal 31 (9), 3950, 2017 | 42 | 2017 |
| Interactions of lipids, lipoproteins, and apolipoproteins with the blood-brain barrier EM Rhea, WA Banks Pharmaceutical research 38 (9), 1469-1475, 2021 | 39 | 2021 |
